Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 1:42 pm Purchase | 13G | LA JOLLA PHARMACEUTICAL COMP LJPC | RTW INVESTMENTS LP | 2,551,020 9.39% | 276,651 (+12.16%) | View |
| 2020-02-13 5:24 pm Purchase | 13G | LA JOLLA PHARMACEUTICAL COMP LJPC | Broadfin Capital LLC | 2,688,068 9.9% | 740,527 (+38.02%) | View |
| 2020-02-13 08:32 am Sale | 13G | LA JOLLA PHARMACEUTICAL COMP LJPC | SECTORAL ASSET MANAGEMENT INC | 0 0% | -1,759,171 (Position Closed) | View |
| 2020-02-07 11:24 am Sale | 13G | LA JOLLA PHARMACEUTICAL COMP LJPC | FMR LLC | 1,255,018 4.621% | -609,833 (-32.70%) | View |
| 2020-02-07 10:06 am Unchanged | 13G | LA JOLLA PHARMACEUTICAL COMP LJPC | JENNISON ASSOCIATES LLC | 0 0% | 0 (Unchanged) | View |
| 2020-02-05 12:16 pm Purchase | 13G | LA JOLLA PHARMACEUTICAL COMP LJPC | BlackRock Inc. BLK | 1,574,336 5.8% | 75,775 (+5.06%) | View |
| 2020-01-14 06:02 am Purchase | 13D | LA JOLLA PHARMACEUTICAL COMP LJPC | TANG CAPITAL PARTNERS LP | 8,220,575 30.2% | 2,983,682 (+56.97%) | View |
| 2019-12-10 09:43 am Sale | 13G | LA JOLLA PHARMACEUTICAL COMP LJPC | FMR LLC | 1,864,851 6.866% | -2,068,500 (-52.59%) | View |
| 2019-06-14 09:28 am Purchase | 13G | LA JOLLA PHARMACEUTICAL COMP LJPC | RTW INVESTMENTS LP | 2,274,369 8.39% | 1,743,304 (+328.27%) | View |